147 related articles for article (PubMed ID: 25789070)
1. Clinical implications of insulin-like growth factor II mRNA-binding protein 3 expression in non-small cell lung carcinoma.
Zhang J; Ou Y; Ma Y; Zheng L; Zhang X; Xia R; Kong F; Shen Y; Wang S; Lin L
Oncol Lett; 2015 Apr; 9(4):1927-1933. PubMed ID: 25789070
[TBL] [Abstract][Full Text] [Related]
2. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-A in patients with primary non-small-cell lung cancer.
Liu J; Liu Y; Gong W; Kong X; Wang C; Wang S; Liu A
Oncol Lett; 2019 Nov; 18(5):4744-4752. PubMed ID: 31611984
[TBL] [Abstract][Full Text] [Related]
4. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma.
Lin L; Zhang J; Wang Y; Ju W; Ma Y; Li L; Chen L
Oncol Lett; 2013 Sep; 6(3):740-744. PubMed ID: 24137402
[TBL] [Abstract][Full Text] [Related]
6. Testes-specific protease 50 as an independent risk factor for poor prognosis in patients with non-small cell lung cancer.
Qiao WL; Shi BW; Han YD; Tang HM; Lin J; Hu HY; Lin Q
Oncol Lett; 2018 Jun; 15(6):8796-8804. PubMed ID: 29805619
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
8. Clinical implications of high NQO1 expression in breast cancers.
Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
10. [Expression of insulin-like growth factor 2 mRNA-binding protein 3 expression and analysis of prognosis in the patients with lung squamous cell carcinoma].
Lin L; Zhang J; Wang Y; Zheng L; Lin Z; Cai Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):694-7. PubMed ID: 23837977
[TBL] [Abstract][Full Text] [Related]
11. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
12. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
13. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
[TBL] [Abstract][Full Text] [Related]
14. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
[TBL] [Abstract][Full Text] [Related]
16. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
[TBL] [Abstract][Full Text] [Related]
18. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
[TBL] [Abstract][Full Text] [Related]
19. The correlation between insulin-like growth factor II mRNA binding protein 3 expression in hepatocellular carcinoma and prognosis.
Chen LT; Lin LJ; Zheng LL
Hepatogastroenterology; 2013 May; 60(123):553-6. PubMed ID: 23159356
[TBL] [Abstract][Full Text] [Related]
20. Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma.
Lin L; Qin Y; Jin T; Liu S; Zhang S; Shen X; Lin Z
Exp Mol Pathol; 2014 Apr; 96(2):200-5. PubMed ID: 24384455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]